INS and hyperlipidemia: For example, hyperglycemia/hyperlipidemia-induced oxidative stress and inflammation may activate platelets either directly or by impairing NO bioavailability [56,57] while at the same time insulin can exert mild antiplatelet effects, at least in insulin sensitive subjects [58,59,60].